RITA Medical to Present at the Thomas Weisel Partners Healthcare Conference 2006 FREMONT, Calif., Sept. 6 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it will present at the

AngioDynamics Announces That Court Denies Diomed's Summary Motion for Infringement QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 31, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the U. S. District Judge Nathaniel M. Gorton has ruled on summary judgment motions in the Diomed patent

AngioDynamics Fourth Quarter Results Feature Net Sales up 36%; Company Introduces Fiscal 2007 Financial Guidance; Conference Call Begins Today at 4:30 p.m. Eastern Time QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 10, 2006--AngioDynamics, Inc. (Nasdaq: ANGO) today announced financial results for the 13

Company Achieves Record $12.8 Million Revenue; Expects Key Product
Introductions in Second Half of Year

AngioDynamics to Present at the 26th Annual Canaccord Adams Summer Seminar QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 2, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that its chief financial officer, Joseph G. Gerardi, will make a formal presentation at the 26th Annual Canaccord Adams

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 1, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the company will release fiscal 2006 fourth quarter results after the market closes on Thursday, August 10, 2006. Eamonn P. Hobbs, president and chief executive officer, and Joseph G.

FREMONT, Calif., July 20 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it will release financial results for the second quarter ended June 30, 2006, after the market close on Tuesday, August 8, 2006. The Company will also host a conference call and live

QUEENSBURY, N.Y., Jul 13, 2006 (BUSINESS WIRE) -- AngioDynamics, Inc., (NASDAQ:ANGO) today announced that it has amended its agreement with Bioniche Pharma Group Limited to expand its market to be the sole distributor of Sotradecol ™ for the treatment of small, uncomplicated varicose veins

Innovative Embolization Technology Used to Treat Cancerous Liver Tumors FREMONT, Calif., July 11 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced the Company has begun sales of the LC

FREMONT, Calif., July 7 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the C. E. Unterberg, Towbin Emerging Growth Conference, which will take

QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 27, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the summary judgment hearing in the Diomed patent litigation lawsuit in the federal district court in Massachusetts has been postponed due to an Order of Recusal by Judge Richard G. Stearns.

FREMONT, Calif., June 9 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the Pacific Growth Equities Life Sciences Growth Conference, which will

FREMONT, Calif., June 9 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at Needham & Company, LLC's Fifth Annual Biotechnology and Medical

FREMONT, Calif., June 8 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that the Company held its Annual Meeting of Stockholders on Wednesday, June 7, 2006, at its corporate headquarters in Fremont, CA, as scheduled.

Preliminary Research Shows Potential Benefit of Combining Arterial Embolization with Doxorubicin Eluting Beads and Radiofrequency Ablation to Treat Primary Liver Cancer <br /><br />Separate Study Shows Increased Median Survival Following RFA for Patients with Lung Metastases from Colorectal Cancer

QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 24, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that it is offering 2,400,000 shares of its common stock at a public offering price of $24.07 per share. The offering is expected to close on May 30, 2006 and is subject to the satisfaction of

FREMONT, Calif., May 15, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the 2006 Robins Emerging Opportunities

QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 9, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced the nationwide launch of the MORPHEUS ® CT PICC INSERTION KIT. Use of the INSERTION KIT allows the Company's proprietary peripherally inserted central catheter (PICC) to be inserted at a patient's

Company Achieves a Record $12.5 Million in Revenue and Also Reduces Operating Loss; Generates Positive Cash Flow From Operations

Product Designed as a Minimally Invasive Treatment for Hypervascularized Malignant Cancer Tumors FREMONT, Calif. and FARNHAM, United Kingdom, April 27 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) a publicly traded company focused solely on cancer therapies, today announced